JPS63198695A - レベカマイシン類似体 - Google Patents

レベカマイシン類似体

Info

Publication number
JPS63198695A
JPS63198695A JP62293854A JP29385487A JPS63198695A JP S63198695 A JPS63198695 A JP S63198695A JP 62293854 A JP62293854 A JP 62293854A JP 29385487 A JP29385487 A JP 29385487A JP S63198695 A JPS63198695 A JP S63198695A
Authority
JP
Japan
Prior art keywords
alkyl
formula
rebecamycin
alkoxy
alkoxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62293854A
Other languages
English (en)
Japanese (ja)
Other versions
JPH05400B2 (enExample
Inventor
タクシ　カネコ
ヘンリ　エス　ウォン
ジェイコブ　ジェイ　ウッツィグ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS63198695A publication Critical patent/JPS63198695A/ja
Publication of JPH05400B2 publication Critical patent/JPH05400B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
JP62293854A 1986-11-21 1987-11-20 レベカマイシン類似体 Granted JPS63198695A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/933,428 US4785085A (en) 1986-11-21 1986-11-21 Rebeccamycin analogs
US933428 1992-08-21

Publications (2)

Publication Number Publication Date
JPS63198695A true JPS63198695A (ja) 1988-08-17
JPH05400B2 JPH05400B2 (enExample) 1993-01-05

Family

ID=25463937

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62293854A Granted JPS63198695A (ja) 1986-11-21 1987-11-20 レベカマイシン類似体

Country Status (28)

Country Link
US (1) US4785085A (enExample)
EP (1) EP0269025B1 (enExample)
JP (1) JPS63198695A (enExample)
KR (1) KR910000897B1 (enExample)
CN (1) CN1019806B (enExample)
AT (1) ATE84539T1 (enExample)
AU (1) AU614068B2 (enExample)
CA (1) CA1287349C (enExample)
CS (1) CS265248B2 (enExample)
CY (1) CY1701A (enExample)
DE (1) DE3783577T2 (enExample)
DK (1) DK165986C (enExample)
EG (1) EG18409A (enExample)
ES (1) ES2053510T3 (enExample)
FI (1) FI86189C (enExample)
GR (1) GR3006776T3 (enExample)
HK (1) HK49093A (enExample)
HU (1) HU201773B (enExample)
IE (1) IE60595B1 (enExample)
IL (1) IL84515A (enExample)
MX (1) MX9202849A (enExample)
MY (1) MY102722A (enExample)
NO (1) NO167741C (enExample)
NZ (1) NZ222544A (enExample)
PT (1) PT86188B (enExample)
SG (1) SG25193G (enExample)
YU (1) YU46087B (enExample)
ZA (1) ZA878714B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030682A1 (en) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
WO1997009339A1 (fr) * 1995-09-05 1997-03-13 Banyu Pharmaceutical Co., Ltd. Derives antitumoraux d'indolopyrrolocarbazole
WO2005026185A1 (ja) * 2003-09-16 2005-03-24 Banyu Pharmaceutical Co., Ltd. 抗腫瘍性新規インドロピロロカルバゾール誘導体

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
US5496809A (en) * 1989-05-10 1996-03-05 Bristol-Myers Squibb Co Stable solutions of rebeccamycin analog
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
JPH0725787B2 (ja) * 1990-03-06 1995-03-22 ブリストル−マイヤーズ スクイブ カンパニー 臭化物前駆物質物質供給によるレベカマイシン類似体
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
EP0528030B1 (en) * 1990-05-11 1997-09-17 Banyu Pharmaceutical Co., Ltd. Antitumor be-13793c derivative
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5437996A (en) * 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
CA2130836A1 (en) * 1992-03-20 1993-09-30 Martin J. Slater Further indole derivatives with antiviral activity
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
PL182124B1 (pl) * 1993-12-07 2001-11-30 Lilly Co Eli Nowe zwiazki oraz srodek farmaceutyczny przeznaczony do leczenia powiklan cukrzycowych lub do leczenia nowotworów PL PL PL PL PL PL PL PL
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
EP0657411B1 (en) * 1993-12-07 1999-06-09 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
DK0817627T3 (da) * 1993-12-23 2005-06-06 Lilly Co Eli Inhibitorer af proteinkinase C
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5804564A (en) * 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
JP3707075B2 (ja) * 1994-06-13 2005-10-19 萬有製薬株式会社 グリコシルトランスフェラーゼをコードする遺伝子及びその用途
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
ES2123873T3 (es) * 1994-08-04 1999-01-16 Hoffmann La Roche Pirrolocarbazol.
KR20000064764A (ko) * 1996-03-20 2000-11-06 피터지.스트링거 인돌릴말레이미드의제조방법
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
JP2004534006A (ja) 2001-03-22 2004-11-11 ブリストル−マイヤーズ　スクイブ　カンパニー インドロピロロカルバゾール化合物のトポイソメラーゼｉ選択的細胞毒シュガー誘導体
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102898489B (zh) * 2010-11-24 2014-04-02 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法
CN102125578B (zh) * 2010-11-24 2013-03-27 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4552842A (en) * 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030682A1 (en) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
WO1997009339A1 (fr) * 1995-09-05 1997-03-13 Banyu Pharmaceutical Co., Ltd. Derives antitumoraux d'indolopyrrolocarbazole
WO2005026185A1 (ja) * 2003-09-16 2005-03-24 Banyu Pharmaceutical Co., Ltd. 抗腫瘍性新規インドロピロロカルバゾール誘導体

Also Published As

Publication number Publication date
DK165986B (da) 1993-02-22
CS824987A2 (en) 1989-01-12
YU46087B (sh) 1992-12-21
CN1019806B (zh) 1992-12-30
CN87107928A (zh) 1988-08-10
AU614068B2 (en) 1991-08-22
ES2053510T3 (es) 1994-08-01
ZA878714B (enExample) 1988-05-20
FI875091A7 (fi) 1988-05-22
FI86189C (fi) 1992-07-27
SG25193G (en) 1993-05-21
MX9202849A (es) 1992-06-30
CY1701A (en) 1994-01-14
EP0269025B1 (en) 1993-01-13
KR910000897B1 (ko) 1991-02-12
FI875091A0 (fi) 1987-11-18
US4785085A (en) 1988-11-15
CS265248B2 (en) 1989-10-13
JPH05400B2 (enExample) 1993-01-05
YU208687A (en) 1988-10-31
CA1287349C (en) 1991-08-06
DK612987D0 (da) 1987-11-20
DK165986C (da) 1993-07-19
IL84515A (en) 1991-11-21
AU8114887A (en) 1988-05-26
GR3006776T3 (enExample) 1993-06-30
ATE84539T1 (de) 1993-01-15
NO874857D0 (no) 1987-11-20
EP0269025A2 (en) 1988-06-01
EG18409A (en) 1993-02-28
NO874857L (no) 1988-05-24
IL84515A0 (en) 1988-04-29
NZ222544A (en) 1990-11-27
PT86188B (pt) 1990-11-07
NO167741C (no) 1991-12-04
DE3783577T2 (de) 1993-05-19
HU201773B (en) 1990-12-28
DK612987A (da) 1988-05-22
HK49093A (en) 1993-05-27
FI86189B (fi) 1992-04-15
IE873152L (en) 1988-05-21
KR880006246A (ko) 1988-07-22
DE3783577D1 (de) 1993-02-25
PT86188A (en) 1987-12-01
MY102722A (en) 1992-09-30
NO167741B (no) 1991-08-26
HUT45543A (en) 1988-07-28
EP0269025A3 (en) 1990-08-29
IE60595B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
US4785085A (en) Rebeccamycin analogs
US4808613A (en) Rebeccamycin derivative containing pharmaceutical composition
KR100312445B1 (ko) 트리플루오로메틸피롤로인돌카르복실산 에스테르 유도체의 제조방법
NZ245203A (en) 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
JPS5936999B2 (ja) ２′，３′−保護５′−デオキシ−５−フルオロシチジン及び−ウリジン
US3868373A (en) 4-Amino-5-fluoro-2-tri(lower alkyl) silyloxypyrimidines
US4639454A (en) Phenylquinazolinecarboxylic acids and derivatives as cancer chemotherapeutic agents
WO1991018003A1 (fr) Derive antitumoral de be-13793c
EP0683788B1 (en) 3'-aziridino-anthracycline derivatives
US20080113927A1 (en) Indolopyrrolocarbazole derivatives and anti-tumor agent
HU217551B (hu) 6[(2-Hidroxi-etil)-amino-alkil]-5,11-dioxo-5,6-dihidro-11H-indén[1,2-c]izokinolin-származékok, valamint eljárás előállításukra, továbbá hatóanyagként e vegyületeket tartalmazó gyógyászati készítmények
JPH08509740A (ja) カンプトテシンの水溶性誘導体
US4275192A (en) Bis(4-demethoxydaunorubicin)dihydrazone derivatives and pharmacologically acceptable salts thereof
NZ205669A (en) Anthracycline glycosides,intermediates,and pharmaceutical compositions
US3691199A (en) 2-hydroxy-indole-3-dithiocarboxylates
EP0601520A1 (en) Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same
JP2655003B2 (ja) ５―置換ウリジン誘導体及びその製造中間体
US20060189800A1 (en) Indolopyrrolocabazole derivative and antitumor agent
JPH0631303B2 (ja) 新規な６位置換アルドヘキソピラノ−ス誘導体
JPS6351385A (ja) 新規なジアミノピリミド〔４，５−ｄ〕ピリミジングリコシドおよびグリコチド
GB2287463A (en) Bis-anthracycline derivatives
JPS6399071A (ja) マイトマイシン誘導体
JPS6270376A (ja) ジスルフイド化合物及び抗腫瘍剤